Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1735.00 | 1870.75 | 0.9274 | 0.8988 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 1250.00 | 684.27 | 1666.00 | 1870.75 | 0.8906 | 0.8464 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 684.27 | 1800.00 | 1870.75 | 0.9622 | 0.9476 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 2063.00 | 1870.75 | 1.1028 | 1.1395 |
| BT-20 | Erlotinib | 1 | uM | 9 | 1250.00 | 684.27 | 1784.00 | 1870.75 | 0.9536 | 0.9356 |
| BT-20 | Lapatinib | 10 | uM | 9 | 1250.00 | 684.27 | 845.00 | 1870.75 | 0.4517 | 0.1565 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1887.00 | 1870.75 | 1.0087 | 1.0120 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 684.27 | 1951.00 | 1870.75 | 1.0429 | 1.0587 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 684.27 | 1988.00 | 1870.75 | 1.0627 | 1.0856 |
| BT-20 | Lapatinib | 1 | uM | 9 | 1250.00 | 684.27 | 1838.00 | 1870.75 | 0.9825 | 0.9758 |
| BT-20 | Linsitinib | 10 | uM | 9 | 1250.00 | 684.27 | 1738.00 | 1870.75 | 0.9290 | 0.9011 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1866.00 | 1870.75 | 0.9975 | 0.9965 |
| BT-20 | Erlotinib | 10 | uM | 9 | 1250.00 | 684.27 | 1259.00 | 1870.75 | 0.6730 | 0.5223 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 684.27 | 1877.00 | 1870.75 | 1.0033 | 1.0046 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 1250.00 | 684.27 | 1880.00 | 1870.75 | 1.0049 | 1.0068 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 1250.00 | 684.27 | 1078.00 | 1870.75 | 0.5762 | 0.3679 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1629.00 | 1870.75 | 0.8708 | 0.8181 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 684.27 | 1929.00 | 1870.75 | 1.0311 | 1.0427 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1990.00 | 1870.75 | 1.0637 | 1.0870 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 684.27 | 1936.00 | 1870.75 | 1.0349 | 1.0478 |
| BT-20 | Linsitinib | 1 | uM | 9 | 1250.00 | 684.27 | 1748.00 | 1870.75 | 0.9344 | 0.9086 |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1812.00 | 1870.75 | 0.9686 | 0.9565 | |
| BT-20 | 0 | uM | 9 | 1250.00 | 684.27 | 1693.00 | 1870.75 | 0.9050 | 0.8670 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 684.27 | 1064.00 | 1870.75 | 0.5688 | 0.3556 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 684.27 | 1657.00 | 1870.75 | 0.8857 | 0.8396 |